Add Yahoo as a preferred source to see more of our stories on Google. Blood clot made of red blood cells, platelets and fibrin protein strands. Thrombus, 3D illustration (Getty Images/iStockphoto) A ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults ...

The US Food and Drug Administration (FDA) has approved the biologic Adzynma (ADAMTS13, recombinant-krhn, Takeda Pharmaceuticals) to treat adults and children who have a rare and life-threatening blood ...

A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura. A team led by investigators from ...

(RTTNews) - Takeda (TAK) said that the U.S. Food and Drug Administration has accepted Takeda's Biologics License Application for TAK-755, an enzyme replacement therapy for the treatment of congenital ...

A potentially fatal disorder which causes blood clotting has been linked to a common cold, according to researchers from the University of North Carolina School of Medicine. The team found a ...

CHAPEL HILL, N.C. – Platelets, or thrombocytes, are specialized cellular fragments that form blood clots when we get scrapes and traumatic injuries. Viral infections, autoimmune disease, and other ...